DE60225845D1 - Zusammensetzungen und verfahren zur diagnose und behandlung von diabetes, insulinresistenz und dyslipidämie - Google Patents

Zusammensetzungen und verfahren zur diagnose und behandlung von diabetes, insulinresistenz und dyslipidämie

Info

Publication number
DE60225845D1
DE60225845D1 DE60225845T DE60225845T DE60225845D1 DE 60225845 D1 DE60225845 D1 DE 60225845D1 DE 60225845 T DE60225845 T DE 60225845T DE 60225845 T DE60225845 T DE 60225845T DE 60225845 D1 DE60225845 D1 DE 60225845D1
Authority
DE
Germany
Prior art keywords
methods
diabetes
dyslipidemia
insulin resistance
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60225845T
Other languages
English (en)
Inventor
Steve Waters
Shonna Moodie
Brian Lavan
Thomas A Gustafson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CymaBay Therapeutics Inc
Original Assignee
Metabolex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabolex Inc filed Critical Metabolex Inc
Application granted granted Critical
Publication of DE60225845D1 publication Critical patent/DE60225845D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60225845T 2001-12-17 2002-12-16 Zusammensetzungen und verfahren zur diagnose und behandlung von diabetes, insulinresistenz und dyslipidämie Expired - Lifetime DE60225845D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34145101P 2001-12-17 2001-12-17
PCT/US2002/040397 WO2003051182A2 (en) 2001-12-17 2002-12-16 Compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia

Publications (1)

Publication Number Publication Date
DE60225845D1 true DE60225845D1 (de) 2008-05-08

Family

ID=23337630

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60225845T Expired - Lifetime DE60225845D1 (de) 2001-12-17 2002-12-16 Zusammensetzungen und verfahren zur diagnose und behandlung von diabetes, insulinresistenz und dyslipidämie

Country Status (8)

Country Link
US (1) US7510851B2 (de)
EP (1) EP1465911B1 (de)
JP (1) JP2005520497A (de)
AT (1) ATE390435T1 (de)
AU (1) AU2002360637B2 (de)
CA (1) CA2470431A1 (de)
DE (1) DE60225845D1 (de)
WO (1) WO2003051182A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7054758B2 (en) * 2001-01-30 2006-05-30 Sciona Limited Computer-assisted means for assessing lifestyle risk factors
US8299043B2 (en) * 2006-04-28 2012-10-30 Mayo Foundation For Medical Education And Research Treating glaucoma, cardiovascular diseases, and renal diseases
JP5283106B2 (ja) * 2008-03-14 2013-09-04 国立大学法人 熊本大学 Ｃ型肝炎ウイルス阻害剤
JP6023045B2 (ja) * 2010-05-27 2016-11-09 ファルマツェル、ゲーエムベーハー 新規７α−ヒドロキシステロイドデヒドロゲナーゼノックアウト突然変異体およびその使用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60142984A (ja) * 1983-12-28 1985-07-29 Kyorin Pharmaceut Co Ltd 新規なスピロピロリジン−２，５−ジオン誘導体およびその製造法
US6124115A (en) * 1995-09-22 2000-09-26 Endorecherche Inc. Production and use of isolated type 5 17β-hydroxysteroid dehydrogenase
US5756299A (en) * 1996-12-09 1998-05-26 Incyte Pharmaceuticals, Inc. Human carbonyl reductase
US6001353A (en) * 1997-05-09 1999-12-14 The Board Of Trustees Of The Univeristy Of Illinois 20α-alpha-hydroxy steroid dehydrogenase related material and methods
WO1999056768A1 (en) * 1998-05-06 1999-11-11 Metamorphix, Inc. Methods for treating diabetes by inhibiting gdf-8
AU2001255330A1 (en) * 2000-04-12 2001-10-30 Genaissance Pharmaceuticals, Inc. Haplotypes of the akr1b1 gene
AU2002245214A1 (en) * 2001-01-04 2002-07-16 Myriad Genetics, Inc. Protein-protein interactions
KR100423912B1 (ko) 2001-05-04 2004-03-24 삼성전자주식회사 씨모스형 반도체 장치 형성 방법

Also Published As

Publication number Publication date
CA2470431A1 (en) 2003-06-26
WO2003051182A2 (en) 2003-06-26
AU2002360637B2 (en) 2007-08-30
JP2005520497A (ja) 2005-07-14
WO2003051182A3 (en) 2004-08-12
ATE390435T1 (de) 2008-04-15
US20030186871A1 (en) 2003-10-02
AU2002360637A1 (en) 2003-06-30
US7510851B2 (en) 2009-03-31
EP1465911A2 (de) 2004-10-13
EP1465911B1 (de) 2008-03-26
EP1465911A4 (de) 2006-04-19

Similar Documents

Publication Publication Date Title
ATE440536T1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
DE602005024850D1 (de) Verfahren zur diagnose und behandlung von schwangerschaftsskomplikationen
BR0111125A (pt) Moléculas de ácido nucléico de nrg-2, polipeptìdeos, e métodos diagnóstico e terapêuticos
ATE419390T1 (de) Verfahren zur diagnose von bauchspeicheldrüsenkrebs
ATE453653T1 (de) Platinkomplexe zur behandlung von tumoren
ATE321570T1 (de) Verfahren zur behandlung von hämostatischen störungen durch lösliches p-selectin
ATE466014T1 (de) Spiroazacyclische verbindungen als monoaminrezeptormodulatoren
ATE536855T1 (de) Gewebegerüste zusamensetzungen zur behandlung von zahnerkrankungen
HUP0301729A2 (hu) Gyógyszer szívelégtelenség megelżzésére és kezelésére
WO2006017171A3 (en) Methods of diagnosing & treating obesity, diabetes and insulin resistance
ATE356995T1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
ATE338142T1 (de) Methoden zur diagnose und behandlung von herzkrankheiten
EA200700951A1 (ru) БЕЛКИ, СОДЕРЖАЩИЕ ДОМЕНЫ vWFA И/ИЛИ ANT_IG
DE60126248D1 (de) Verwendung von brustkrebs membranproteine für behandlung, prophylaxe und diagnose von brustkrebs
DE602004029061D1 (de) Zusammensetzungen, reagenzien, kits und verfahren für die diagnose und behandlung von fettleibigkeit und/oder diabetes
ATE390435T1 (de) Zusammensetzungen und verfahren zur diagnose und behandlung von diabetes, insulinresistenz und dyslipidämie
WO2003101284A3 (en) Methods of diagnosing and treating diabetes and insulin resistance
ATE393785T1 (de) Glykopeptide, deren herstellung und verwendung in der diagnose oder behandlung von multipler sklerose
WO2003103597A3 (en) DIAGNOSIS AND TREATMENT OF DIABETES AND INSULIN RESISTANCE
WO2003103601A3 (en) DIAGNOSIS AND TREATMENT METHODS FOR DIABETES AND INSULIN RESISTANCE
WO2003102161A3 (en) Methods of diagnosing & treating diabetes and insulin resistance
WO2006010051A3 (en) Methods of diagnosing & treating diabetes and insulin resistance
ATE516813T1 (de) Verfahren und verbindungen zur behandlung von diabetes
CY1110278T1 (el) Μεθοδος διαλογης παραγοντων ικανων να θεραπευουν την παχυσαρκια
ATE363075T1 (de) Verfahren zur diagnose und behandlung von metastasen und dafür nützliche zusammensetzung

Legal Events

Date Code Title Description
8332 No legal effect for de